Top

Cancer Cell International

Published in:

Open Access 01-12-2024 | Gastric Cancer | Retraction Note

Retraction Note: GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway

Authors: Hong Chen, Lu Xu, Zhi-li Shan, Shu Chen, Hao Hu

Published in: Cancer Cell International | Issue 1/2024

Excerpt

Cancer Cell International (2020) 20:596 …

Bi F, Chen C, Fu J, Yu L, Geng J. Inhibiting proliferation and metastasis of osteosarcoma cells by downregulation of long non–coding RNA colon cancer–associated transcript 2 targeting microRNA–143 retraction in /10.3892/ol.2023.13665. Oncol Lett. 2021;21:265. https://doi.org/10.3892/ol.2021.12526.CrossRefPubMedPubMedCentral

Zhang S, Chen Z, Sun J, et al. CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis. Cancer Cell Int. 2020;20:287. https://doi.org/10.1186/s12935-020-01387-5.CrossRefPubMedPubMedCentral

Title: Retraction Note: GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway
Authors: Hong Chen
Lu Xu
Zhi-li Shan
Shu Chen
Hao Hu
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Gastric Cancer
Gastric Cancer
Published in: Cancer Cell International / Issue 1/2024
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-024-03269-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Low TYROBP expression predicts poor prognosis in multiple myeloma

NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route

CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling

Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma

NEK2 contributes to radioresistance in esophageal squamous cell carcinoma by inducing protective autophagy via regulating TRIM21

Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression

Keynote webinar | Spotlight on antibody–drug conjugates in cancer